Mark Lee
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
Papers in
-
- Head and Neck Cancer Studies 6
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Stefanie S. Jeffrey (3 shared papers)Michail Ignatiadis (1 shared paper)Alexander M. Aravanis (1 shared paper)Richard D. Klausner (1 shared paper)Kevin Struhl (2 shared papers)Frederick L. Baehner (2 shared papers)Laura Magill (1 shared paper)Kelly Handley (1 shared paper)
- Journals
- Nature Medicine (3 papers)Oncotarget (3 papers)Palliative Medicine (3 papers)Blood (2 papers)Journal of Palliative Care (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Mark Lee
53 papers receiving 2.6k citations
Mark Lee's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 975
- Oncology 546
- Otorhinolaryngology 75
- Health Informatics 22
- Pathology and Forensic Medicine 136
Countries citing papers authored by Mark Lee
This map shows the geographic impact of Mark Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lee more than expected).
Fields of papers citing papers by Mark Lee
This network shows the impact of papers produced by Mark Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lee. The network helps show where Mark Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants Hit paper breakdown → | 2019 | 589 |
| 2 | 2015 | 317 | |
| 3 | 2011 | 305 | |
| 4 | 2017 | 292 | |
| 5 | 2023 | 113 | |
| 6 | 2014 | 82 | |
| 7 | 2016 | 79 | |
| 8 | Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data Hit paper breakdown → | 2025 | 72 |
| 9 | 2010 | 58 | |
| 10 | 1995 | 53 | |
| 11 | 2004 | 40 | |
| 12 | 2009 | 38 | |
| 13 | 2009 | 38 | |
| 14 | 2022 | 36 | |
| 15 | 2001 | 33 | |
| 16 | 2020 | 33 | |
| 17 | 1997 | 32 | |
| 18 | 2023 | 30 | |
| 19 | 2011 | 29 | |
| 20 | 2019 | 28 |
About Mark Lee
Mark Lee is a scholar working on Otorhinolaryngology, Cancer Research, Pathology and Forensic Medicine, Neurology and Oncology, having authored 55 papers that have together received 2.6k indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (8 papers), Head and Neck Cancer Studies (6 papers), Cancer Genomics and Diagnostics (6 papers), Genetic factors in colorectal cancer (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Dermatology and Skin Diseases (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Cancer Research (975 citations), Oncology (546 citations), Otorhinolaryngology (75 citations), Health Informatics (22 citations) and Pathology and Forensic Medicine (136 citations). Mark Lee has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Stefanie S. Jeffrey, Michail Ignatiadis, Alexander M. Aravanis, Richard D. Klausner, Kevin Struhl, Frederick L. Baehner, Laura Magill, Kelly Handley, Richard G. Gray and Kim Michelle Clark-Langone. Their work appears in journals such as Nature Medicine, Oncotarget, Palliative Medicine, Blood and Journal of Palliative Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.